These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7699528

  • 1. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group.
    Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV.
    J Pediatr; 1995 Apr; 126(4):515-23. PubMed ID: 7699528
    [Abstract] [Full Text] [Related]

  • 2. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.
    Auerbach HS, Williams M, Kirkpatrick JA, Colten HR.
    Lancet; 1985 Sep 28; 2(8457):686-8. PubMed ID: 2863676
    [Abstract] [Full Text] [Related]

  • 3. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
    Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM.
    N Engl J Med; 2000 Mar 23; 342(12):851-9. PubMed ID: 10727589
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F, German Cystic Fibrosis Growth Hormone Study Group.
    Pediatrics; 2007 Jun 23; 119(6):e1230-8. PubMed ID: 17545356
    [Abstract] [Full Text] [Related]

  • 5. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F, AZ0004 Azithromycin Study Group.
    JAMA; 2010 May 05; 303(17):1707-15. PubMed ID: 20442386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral steroids for cystic fibrosis.
    Cheng K, Ashby D, Smyth R.
    Cochrane Database Syst Rev; 2000 May 05; (2):CD000407. PubMed ID: 10796717
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
    Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA.
    N Engl J Med; 1993 Jun 17; 328(24):1740-6. PubMed ID: 8497284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S, Zielen S.
    Paediatr Drugs; 2005 Jun 17; 7(6):353-63. PubMed ID: 16356023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.